How2Exit

OCTOBER 2, 2023

rn Businesses can increase their value by working with professionals who can help them reach higher revenue thresholds and attract private equity firms. Industries such as veterinarian services, pet services, and health services are particularly attractive to buyers due to their resilience in the face of economic downturns.

Mergers and Acquisitions 130

Mergers and Acquisitions Business M&A Mergers 130

Software Equity Group

MARCH 13, 2023

While some public strategics backed off, they were more than made up for by private equity companies with plenty of dry powder and a healthy competitive environment. speaks to a healthy environment, with multiples shored up by private equity buyers on the hunt for high-quality assets. was only a slight decline from 2020’s 5.7x

M&A 52

M&A Private Equity Equities S&P 52

Software Equity Group

MAY 7, 2024

2023 saw a myriad of factors impact SaaS M&A multiples, including economic developments, technological advancements, and a public market rebound. In any given year, however, some sectors of the SaaS universe are more prosperous than others, depending on industry trends, global economics, and other influences.

M&A 52

M&A Valuation Economics Business 52

Software Equity Group

MAY 8, 2024

2023 saw a myriad of factors impact SaaS M&A multiples, including economic developments, technological advancements, and a public market rebound. In any given year, however, some sectors of the SaaS universe are more prosperous than others, depending on industry trends, global economics, and other influences.

M&A 52

M&A Valuation Economics Business 52

Focus Investment Banking

JUNE 13, 2023

On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a private equity group. Alliance Health Services. US Oncology Network.

Hospitality 52

Hospitality Private Equity Mergers and Acquisitions Medical 52

Intrepid Banker Insights

MARCH 28, 2023

Intrepid Investment Bankers Warning Signs Your Business’s Liquidity Needs Attention Mixed signals dominate economic headlines as concerns persist about a recession beginning in 2023, if it has not already begun. At the same time, employment remains strong, with the unemployment rate hitting an all-time low.

Capital 52

Capital Advisory Banking Bank 52

Cooley M&A

MARCH 1, 2019

Even for a thriving business with a viable equity story, committed stakeholders and the right advisers, the final deal terms and valuation are typically guided by factors beyond a company’s control. Stock market forces also make the timing of an eventual outright exit and the final blended valuation of equity sales over time uncertain.

IPO 52

IPO Valuation M&A Business 52

Focus Investment Banking

AUGUST 6, 2023

ESG isn’t just a matter for large, publicly traded companies. While many people see this as merely “doing the right thing,” there is also often an economic payoff. This is particularly true if your partners are publicly traded or foreign-owned. It’s increasingly becoming a must for small and medium-sized businesses.

Middle Market 52

Middle Market Business Government Profitability 52

Wall Street Mojo

FEBRUARY 9, 2024

When listed as publicly traded companies, they mostly become small-cap and micro-cap stocks trading on the exchange. At the same time, lower middle market private equity firms are more interested in this segment because of the variety of firms they get to seek across different sectors and industries.

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

Cooley M&A

JANUARY 19, 2023

The Inflation Reduction Act imposes a 1% excise tax on certain repurchases of stock of publicly traded US corporations (“Covered Corporations”) effected after December 31, 2022 (the “Excise Tax”). [1] The Notice does not extend the netting rule to deSPAC transactions where target shareholders do not receive SPAC stock (e.g.,

M&A 52

M&A Capital Market Stock Mergers and Acquisitions 52

The Deal

JULY 20, 2023

Advisers to activists and companies, however, both agree that the collection of data in the memorandum isn’t useful in identifying the extent to which activist investors employ cash-settled equity swaps for their campaigns — or how the proposal if adopted would affect their strategies. The fund wants to remove the company’s CEO.

Funds 52

Funds Investors Shares Investment 52

Software Equity Group

FEBRUARY 28, 2023

Stock prices and valuations of many leading public SaaS companies have fallen drastically from the beginning of 2022—but while that will affect the private market, it does not necessarily spell doom and gloom. This post will examine the current state of public SaaS company valuations and what it means for private companies.

Valuation 52

Valuation M&A Stock Profitability 52

Software Equity Group

FEBRUARY 12, 2024

In recent years, software buyers have been keenly focused on gross revenue retention (GRR) and gross profit margin (GPM) , largely because strong performance in these areas provides security amid uncertain economic conditions. The post How to Prepare an Exit Strategy: A Guide for SaaS Founders appeared first on Software Equity Group.

M&A 52

M&A Mergers and Acquisitions Business Valuation 52

Cooley M&A

SEPTEMBER 16, 2022

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. of the transaction’s equity value. [15].

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

RKJ Partners

AUGUST 6, 2017

To be more specific, business valuation is a process involving a set of procedures and approaches used to gauge the economic value of an ownership interest in a business as a going concern. Essentially, comparable company analysis looks at the value of publicly traded companies.

M&A 40

M&A Valuation Mergers and Acquisitions Discounted Cash Flow 40

Cooley M&A

JANUARY 25, 2023

Moreover, going-public transactions between life sciences companies and special purpose acquisition companies (SPACs) decreased significantly in 2022, with fewer investors willing to participate in private investments in public equity (PIPEs) as part of a de-SPAC transaction.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Software Equity Group

OCTOBER 22, 2024

In today’s economic climate, retention is everything: Software companies with Net Revenue Retention (NRR) rates above 120% are trading at a remarkable 63% premium over the market median. Because in a world where growth is uncertain, retaining and expanding existing customers is the ultimate competitive advantage.

Valuation 52

Valuation Investors IT Management 52

Cooley M&A

JANUARY 20, 2022

For example, early in 2021, Zimmer Biomet Holdings announced that it would spin off its spine and dental businesses into a new publicly traded company as a way to “optimize resource allocation” among its remaining businesses. There is a history of drugs failing for one use and then being successfully developed for other uses.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

DECEMBER 20, 2024

Private equity-backed ophthalmology groups have seen significant growth over the last eight years, with more than 30 platforms establishing themselves in the market; most completing numerous add-on (individual practice) acquisitions. Other groups have sold within the private equity space.

Private Equity 52

Private Equity Healthcare Equities Sale 52

Focus Investment Banking

FEBRUARY 11, 2025

McKessons acquisition of PRISM Vision Group is an important milestone for private equitys investments in optometry practices. At the same time, there has always been uncertainty about the ultimate home for these assets, since private equity does not keep its investments forever.

Private Equity 52

Private Equity Healthcare Equities Medical 52